MCID: RHN004
MIFTS: 63

Rhinitis

Categories: Bone diseases, Respiratory diseases, Smell/Taste diseases

Aliases & Classifications for Rhinitis

MalaCards integrated aliases for Rhinitis:

Name: Rhinitis 12 30 56 45 15 17 74
Runny Nose 12 3

Classifications:



External Ids:

Disease Ontology 12 DOID:4483
MeSH 45 D012220
NCIt 51 C34986
SNOMED-CT 69 70076002
UMLS 74 C0035455

Summaries for Rhinitis

CDC : 3 Sore throat and runny nose are usually the first signs of a cold, followed by coughing and sneezing. Most people recover in about 7-10 days. You can help reduce your risk of getting a cold: wash your hands often, avoid close contact with sick people, and don’t touch your face with unwashed hands.

MalaCards based summary : Rhinitis, also known as runny nose, is related to ige responsiveness, atopic and allergic rhinitis, and has symptoms including rhinorrhea, sneezing and sinus congestion. An important gene associated with Rhinitis is IL13 (Interleukin 13), and among its related pathways/superpathways are Innate Immune System and PEDF Induced Signaling. The drugs Allegra and Allegra-D have been mentioned in the context of this disorder. Affiliated tissues include testes, skin and t cells, and related phenotypes are growth/size/body region and hematopoietic system

Disease Ontology : 12 A upper respiratory infectious disease which involves irritation and inflammation of the mucous membrane of the nose due to viruses, bacteria or irritants. The inflammation results in generation of excessive amounts of mucus leading to runny nose, as well as nasal congestion and post-nasal drip.

Wikipedia : 77 Rhinitis, also known as coryza, is irritation and inflammation of the mucous membrane inside the nose.... more...

Related Diseases for Rhinitis

Diseases in the Rhinitis family:

Chronic Rhinitis

Diseases related to Rhinitis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 318)
# Related Disease Score Top Affiliating Genes
1 ige responsiveness, atopic 33.0 IGHE IL13 IL4 IL4R IL5 RNASE3
2 allergic rhinitis 32.6 CCL11 CXCL8 EPX FOXJ1 HRH1 ICAM1
3 pollen allergy 32.4 EPX ICAM1 IL13 IL4R IL5 RNASE3
4 respiratory syncytial virus infectious disease 32.2 CCL5 IL13 IL5
5 common cold 32.0 CCL11 CCL5 CXCL8 ICAM1 IL13 IL5
6 giant papillary conjunctivitis 32.0 CCL11 CXCL8 IL4 RNASE3
7 allergic conjunctivitis 31.9 CCL11 CXCL8 HRH1 ICAM1 IL13 IL4
8 dermatitis 31.5 CCL11 IGHE IL13 IL4 IL5
9 urticaria 31.3 HRH1 IGHE RNASE3
10 bronchiolitis 31.3 CCL11 CCL5 CXCL8 IGHE IL13 IL4
11 sinusitis 31.2 CXCL8 CYSLTR1 IL4R IL5 RNASE3
12 cytokine deficiency 30.9 IL13 IL5
13 otitis media 30.8 CCL11 CXCL8 IGHE IL4 RNASE3
14 pneumonia 30.7 CCL11 CCL5 CXCL8 IL13 IL5
15 bronchitis 30.7 CCL11 CXCL8 IL5 RNASE3
16 food allergy 30.7 EPX IL13 IL4 IL5 RNASE3
17 hypereosinophilic syndrome 30.6 CCL11 EPX IGHE IL13 IL4 IL5
18 allergic asthma 30.6 CCL11 CCL5 EPX IGHE IL13 IL4
19 dermatitis, atopic 30.5 CCL11 CCL5 CXCL8 EPX HRH1 ICAM1
20 esophagitis, eosinophilic, 1 30.5 CCL11 IL13 IL5
21 allergic bronchopulmonary aspergillosis 30.4 EPX IL4 IL5
22 intrinsic asthma 30.4 IL4 IL5 RNASE3
23 esophagitis 30.3 CCL11 CXCL8 IL13 IL5
24 conjunctivitis 30.3 CCL11 CXCL8 EPX HRH1 ICAM1 IL13
25 blepharoconjunctivitis 30.1 CCL11 IL4 RNASE3
26 respiratory allergy 30.1 CCL11 IGHE IL13 IL4 IL4R IL5
27 milk allergy 30.1 IL4 IL5 RNASE3
28 leishmaniasis 30.1 IL13 IL4 IL5
29 contact dermatitis 30.0 CXCL8 ICAM1 IL4 IL5
30 vulvovaginitis 30.0 CCL11 CCL5 CXCL8
31 tetanus 30.0 IL13 IL4 IL5
32 cough variant asthma 30.0 IL4 IL5 NGF RNASE3
33 lung disease 30.0 CCL5 CXCL8 IL13 IL5 RNASE3
34 latex allergy 29.9 IGHE IL13 IL4 IL5 RNASE3
35 pulmonary disease, chronic obstructive 29.9 CCL11 CCL5 CXCL8 IL13 NR3C1 RNASE3
36 multiple sclerosis 29.6 CCL5 ICAM1 IL4 VCAM1
37 allergic hypersensitivity disease 29.5 CCL11 CCL5 EPX HRH1 IGHE IL13
38 keratoconjunctivitis 29.5 CCL11 CXCL8 ICAM1 IL13 IL4 IL5
39 vernal keratoconjunctivitis 29.4 CCL11 CCL5 ICAM1 IL13 IL4 IL5
40 rheumatoid arthritis 29.3 CCL5 CXCL8 ICAM1 IL4 VCAM1
41 asthma 28.7 CCL11 CCL5 CXCL8 CYSLTR1 EPX HRH1
42 chronic rhinitis 12.6
43 vasomotor rhinitis 12.6
44 atrophic rhinitis 12.6
45 asthma-related traits 4 12.0
46 olfactory neuroblastoma 11.4
47 actinobacillosis 11.3
48 influenza 11.3
49 hemicrania continua 11.3
50 swine influenza 11.1

Graphical network of the top 20 diseases related to Rhinitis:



Diseases related to Rhinitis

Symptoms & Phenotypes for Rhinitis

UMLS symptoms related to Rhinitis:


rhinorrhea, sneezing, sinus congestion, nasal congestion (finding), nasal irritation, posterior rhinorrhea

MGI Mouse Phenotypes related to Rhinitis:

47
# Description MGI Source Accession Score Top Affiliating Genes
1 growth/size/body region MP:0005378 10.07 FOXJ1 HRH1 ICAM1 IL13 IL4 IL4R
2 hematopoietic system MP:0005397 9.93 CCL11 CCL5 EPX HRH1 ICAM1 IL13
3 digestive/alimentary MP:0005381 9.87 FOXJ1 ICAM1 IL13 IL4 IL4R IL5
4 immune system MP:0005387 9.8 CCL11 CCL5 CYSLTR1 EPX HRH1 ICAM1
5 respiratory system MP:0005388 9.28 CCL11 CYSLTR1 FOXJ1 IL13 IL4 IL4R

Drugs & Therapeutics for Rhinitis

FDA approved drugs:

(show all 18)
# Drug Name Active Ingredient(s) 19 Company Approval Date
1
Allegra 19 FEXOFENADINE HYDROCHLORIDE Hoechst Marion Roussel July 1996
2
Allegra-D 19 FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE Hoechst Marion Roussel March 1998
3
Astelin nasal spray 19 AZELASTINE HYDROCHLORIDE Wallace Laboratories November 1996
4
Atrovent 19 IPRATROPIUM BROMIDE Boehringer Ingelheim January 1996
5
Clarinex 19 DESLORATADINE Schering-Plough February 2002
6
Clemastine fumarate syrup 19 CLEMASTINE FUMARATE Morton Grove Pharmaceuticals March 1998
7
Dymista 19 AZELASTINE HYDROCHLORIDE; FLUTICASONE PROPIONATE Meda Pharmaceuticals Inc May 2012
8
Flonase Nasal Spray 19 FLUTICASONE PROPIONATE GlaxoSmithKline November 1997
9
Grastek 19 Timothy Grass Pollen Allergen Extract Merck April 2014
10
Nasacort AQ Nasal Spray 19 TRIAMCINOLONE ACETONIDE Phone-Poulenc Rorer October 1997
11
Oralair 19 Greer Labs April 2014
12
Patanase 19 OLOPATADINE HYDROCHLORIDE Alcon April 2008
13
Qnasl 19 BECLOMETHASONE DIPROPIONATE Teva Pharmaceutical March 2012
14
Ragwitek 19 Merck April 2014
15
Rhinocort Aqua Nasal Spray 19 BUDESONIDE AstraZeneca October 1999
16
Tri-Nasal Spray 19 Muro Pharmaceutical February 2000
17
Xyzal 19 LEVOCETIRIZINE DIHYDROCHLORIDE UCB May 2007
18
Zyrtec 19 CETIRIZINE HYDROCHLORIDE Pfizer December 1995

Drugs for Rhinitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 541)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Histamine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 51-45-6 774
2
Dexlansoprazole Approved, Investigational Phase 4,Phase 3 138530-94-6, 103577-45-3 9578005
3
Lansoprazole Approved, Investigational Phase 4,Phase 3 103577-45-3 3883
4
mometasone furoate Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 83919-23-7
5
Capsaicin Approved Phase 4,Phase 2,Phase 1,Not Applicable 404-86-4 1548943
6
Fluticasone Approved, Experimental Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 90566-53-3 62924
7
Azelastine Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 58581-89-8 2267
8
Cetirizine Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 83881-51-0 2678
9
Montelukast Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 158966-92-8 5281040
10
Nitric Oxide Approved Phase 4,Phase 2,Phase 1,Not Applicable 10102-43-9 145068
11
Levocetirizine Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 130018-77-8 1549000
12
Pseudoephedrine Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 90-82-4 7028
13
Methylprednisolone hemisuccinate Approved Phase 4,Phase 3,Phase 2,Early Phase 1 2921-57-5
14
Methylprednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Early Phase 1 83-43-2 6741
15
Ephedrine Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 299-42-3 9294
16
Prednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Early Phase 1 50-24-8 5755
17
Prednisolone phosphate Approved, Vet_approved Phase 4,Phase 3,Phase 2,Early Phase 1 302-25-0
18
Xylometazoline Approved, Investigational Phase 4,Phase 3,Not Applicable 526-36-3 5709
19
Diazepam Approved, Illicit, Investigational, Vet_approved Phase 4,Phase 2 439-14-5 3016
20
Atracurium Approved, Experimental, Investigational Phase 4 64228-79-1 47319
21
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 4,Phase 3,Phase 2 437-38-7 3345
22
Midazolam Approved, Illicit Phase 4 59467-70-8 4192
23
Propofol Approved, Investigational, Vet_approved Phase 4 2078-54-8 4943
24
Atropine Approved, Vet_approved Phase 4,Phase 2,Phase 1 51-55-8, 5908-99-6 174174
25
Ketamine Approved, Vet_approved Phase 4,Phase 1 6740-88-1 3821
26
Oseltamivir Approved Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable 204255-11-8, 196618-13-0 65028
27 Strawberry Approved Phase 4,Phase 3
28
Amoxicillin Approved, Vet_approved Phase 4,Phase 3,Phase 2 26787-78-0 33613
29
Clavulanate Approved, Vet_approved Phase 4,Phase 3 58001-44-8 5280980
30
Desloratadine Approved, Investigational Phase 4,Phase 3,Phase 2,Not Applicable 100643-71-8 124087
31
Phenylephrine Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 59-42-7 6041
32
Oxymetazoline Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 1491-59-4 4636
33
Loratadine Approved, Investigational Phase 4,Phase 3,Phase 2,Not Applicable 79794-75-5 3957
34
Budesonide Approved Phase 4,Phase 3,Phase 2,Not Applicable 51333-22-3 63006 5281004
35
Betamethasone Approved, Vet_approved Phase 4,Phase 3 378-44-9 9782
36
Epinephrine Approved, Vet_approved Phase 4,Phase 3,Phase 2,Not Applicable 51-43-4 5816
37
Racepinephrine Approved Phase 4,Phase 3,Phase 2,Not Applicable 329-65-7 838
38
Omalizumab Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 242138-07-4
39
Guaifenesin Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 93-14-1 3516
40
Acetaminophen Approved Phase 4,Phase 3 103-90-2 1983
41
Ciclesonide Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 141845-82-1, 126544-47-6 444033
42
Fexofenadine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 83799-24-0 3348
43
Resveratrol Approved, Experimental, Investigational Phase 4,Phase 3 501-36-0 445154
44
Triamcinolone Approved, Vet_approved Phase 4,Phase 3,Not Applicable 124-94-7 31307
45
Adenosine Approved, Investigational Phase 4,Phase 2,Phase 1 58-61-7 60961
46
Doxazosin Approved Phase 4 74191-85-8 3157
47
Ethanol Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 64-17-5 702
48
Promethazine Approved, Investigational Phase 4,Phase 3,Phase 1 60-87-7 4927
49
Diphenhydramine Approved, Investigational Phase 4,Phase 3,Phase 1 147-24-0, 58-73-1 3100
50
Prazosin Approved Phase 4 19216-56-9 4893

Interventional clinical trials:

(show top 50) (show all 1384)
# Name Status NCT ID Phase Drugs
1 Immunological Mechanisms of Oralair® in Patients With Seasonal Allergic Rhinitis Unknown status NCT02014623 Phase 4 Control
2 The Relationship Between Gastroesophageal Reflux and Pediatric Rhinitis: Significance of Pale/Blue Colored Turbinate Unknown status NCT02278081 Phase 4 lansoprazole;placebo
3 Assessment of Sublingual Immunotherapy in Children Allergic to House Dust Mites Unknown status NCT01052610 Phase 4 sublingual house dust mites allergen extract;placebo in sublingual applicator
4 Comparative Study of Sinol and Sinol-M in Patients With Congestion Due to Allergic Rhinitis Unknown status NCT00825656 Phase 4 Sinol or Sinol-M nasal spray
5 Elaboration of Patient-friendly Treatment Strategy With Capsaicin Nasal Spray in Patients With Idiopathic Rhinitis Unknown status NCT02288156 Phase 4 Capsaicin;placebo
6 Evaluating Factors Involved in Dymista's Superior Clinical Efficacy to Fluticasone Propionate in the Treatment of Seasonal Allergic Rhinitis Unknown status NCT02402465 Phase 4 Placebo;Fluticasone propionate;Fluticasone/Azelastine nasal spray
7 Comparison of the Effect of Montelukast and Cetirizine on Allergic Inflammation in Children With Allergic Rhinitis Unknown status NCT00488176 Phase 4 montelukast;cetirizine;montelukast and cetirizine;placebo
8 Singulair Use in Non-Allergic Rhinitis Eosinophil Syndrome (NARES) Unknown status NCT00406094 Phase 4 montelukast;placebo
9 AZELASTINE/FLUTICASONE (AZE/FLU) Nasal Spray on Symptom Control, Nasal Mediators and Nasal Hyperresponsiveness in Allergic Rhinitis (AR) Unknown status NCT02238353 Phase 4 azelastine + fluticasone;Placebo
10 Cosalin® Monotherapy Versus Cosalin® and Xarlin® Combination Therapy Unknown status NCT01062139 Phase 4 Xarlin (Levocetirizine);Cosalin (Petasites hybridus CO2 extract)
11 4"S" - Seasonal Symptoms Suppression Study Unknown status NCT02557269 Phase 4 Xylometazoline - intranasal application;Azelastine - intranasal application;Mometasone furoate - intranasal application;Hydroxyl-propyl-methyl cellulose powder - intranasal application;Bilastine 20 mg;Prednisolone 5 mg
12 POLlinosis and Exhaled Breath Temperature Unknown status NCT01785394 Phase 4 5 grass allergen extract
13 A Study of Andrographolide Sulfonate in Patients With Acute Exacerbation of Chronic Bronchitis Unknown status NCT03132610 Phase 4 andrographolide sulfonate;andrographolide sulfonate simulation
14 Evaluate the Efficacy and Safety of Andrographolide Sulfonate in Patients With Acute Tonsillitis Unknown status NCT03134443 Phase 4 Andrographolide sulfonate;Andrographolide sulfonate simulation
15 The Comparison of Different Administration Routes of Pediatric Premedication Unknown status NCT02313337 Phase 4 Anesthesia induction(midazolam,fentanyl,propofol,atracurium);Anesthesia maintenance(midazolam,fentanyl,propofol,atracurium)
16 Comparison of Daily Mometasone Furoate Nasal Spray Alone Versus a Combination With Montelukast for Treatment of Chronic Rhinosinusitis With Asthma After Functional Endoscopic Sinus Surgery Unknown status NCT02110654 Phase 4 Montelukast;mometasone furoate nasal spray
17 Banlangen Granules Anti-seasonal Influenza Study Unknown status NCT02232945 Phase 4 placebo of oseltamivir phosphate;oseltamivir phosphate;Banlangen (Radix Isatidis) granules;placebo of Banlangen(Radix Isatidis) granules
18 Middle Meatal Bacteriology During Acute Respiratory Infection in Children Unknown status NCT00545961 Phase 4 placebo;amoxicillin clavulanate acid
19 Anti-inflammatory H1 Antihistamines Allergic Rhinitis Completed NCT02507635 Phase 4 Levocetirizine;Desloratadine
20 Sunovion Growth Study Pediatric Subjects With Mild Asthma & Allergic Rhinitis Completed NCT01550471 Phase 4 Alvesco/Omnaris, QVAR/Beconase, Placebo/Placebo;Alvesco/Omnaris, Placebo/Placebo, QVAR/Beconase;QVAR/Beconase, Alvesco/Omnaris, Placebo/Placebo;QVAR/Beconase, Placebo/Placebo, Alvesco/Omnaris;Placebo/Placebo, Alvesco/Omnaris, QVAR/Beconase;Placebo/Placebo, QVAR/Beconase, Alvesco/Omnaris
21 Effectiveness of Oxymetazoline Added on Nasal Steroid in Rhinitis With Persistent Nasal Obstruction Completed NCT01847131 Phase 4 oxymetazoline;Placebo nasal spray
22 Quality of Life in Patients With Allergic Rhinitis: Clinical Trial With Bilastine or Loratadine Completed NCT02513290 Phase 4 Bilastine;Loratadine
23 Comparison of Effectiveness and Safety of Sublingual Immunotherapy in Children With Allergic Rhinitis Completed NCT00698594 Phase 4
24 Effectiveness Of Therapy With A Thermal Water Nasal Aerosol In Children With Seasonal Allergic Rhinitis Completed NCT01326247 Phase 4
25 Nasal Budesonide Efficacy on Nasal FeNO in Children With Allergic Rhinitis Completed NCT02409563 Phase 4 Budesonide nasal spray (100 mcg bid);Budesonide nasal spray (50 mcg bid
26 Montelukast and Fexofenadine Versus Montelukast and Levocetrizine Combination in Allergic Rhinitis Completed NCT02551536 Phase 4 Montelukast;Fexofenadine;Levocetrizine
27 Efficacy & Safety of Loratadine-Betamethasone Oral Solution for Treatment of Severe Perennial Allergic Rhinitis in Children (Study P03428) Completed NCT00963573 Phase 4 Loratadine;Betamethasone
28 Nebulized Resveratrol Plus Carboxymethyl-β-Glucan for Reducing IL-5 in Children With Allergic Rhinitis Completed NCT03349619 Phase 4 Resveratrol plus Carboxymethyl-β-Glucan;Placebo
29 Nebulized Beclometasone Dipropionate Improves Nasal Patency in Children With Allergic Rhinitis Completed NCT02646904 Phase 4 Nasal Beclomethasone Dipropionate;CERCHIO 10 mg/ml OS
30 Assessment of Intranasal Steroids in Allergic Rhinitis When Used Alone or in Combination With an Oral Antihistamine (Study P03270) Completed NCT00834119 Phase 4 Mometasone furoate;Mometasone furoate
31 Efficacy and Safety of Lectranal® in Treatment of Seasonal Allergic Rhinitis Symptoms Completed NCT00460538 Phase 4
32 A Clinical Study To Test A Nasal Spray (Fluticasone Furoate Nasal Spray) For The Treatment Of Perennial (Year-round) Allergic Rhinitis Completed NCT00609674 Phase 4 Fluticasone furoate nasal spray;Placebo
33 Efficacy and Tolerability of a Topical Microemulsion in Patients With Allergic Rhinitis Due to Sensitization to Pollen Completed NCT01478425 Phase 4
34 Comparison of Olopatadine 0.6% and Fluticasone Proprionate 50mcg Nasal Sprays in a Two Week Seasonal Allergic Rhinitis Trial Completed NCT00691665 Phase 4 Olopatadine HCL Nasal Spray, 0.6%;Fluticasone Propionate Nasal Spray, 50 mcg
35 Efficacy of Allergen Immunotherapy for Allergic Rhinitis in Thais Completed NCT01115595 Phase 4
36 Montelukast in Mild Asthmatic Children With Allergic Rhinitis (0476-367) Completed NCT00442559 Phase 4 montelukast sodium;inhaled corticosteroid
37 Study of Triamcinolone Acetonide on the Growth Velocity of Children, Ages 3 to 9, With Perennial Allergic Rhinitis (PAR) Completed NCT00449072 Phase 4 TAA-AQ, Nasacort® AQ;Claritin®
38 A Phase-IV, Open-label Study to Evaluate Safety/Tolerability of Once-daily AVAMYS (TM) Aqueous Nasal Spray 110mcg Among Vietnamese Adult Patients With Established Perennial Allergic Rhinitis Completed NCT01270958 Phase 4 Avamys aqueous nasal spray 110mcg
39 Levocetirizine 5 mg: Reduction of Symptoms, Airway Resistance and Sleep Impairment in Persistent Allergic Rhinitis Completed NCT00355771 Phase 4 Levocetirizine;Placebo
40 Compare the Efficacy of Levocetirizine and Montelukast to Placebo in Reducing Seasonal Allergic Rhinitis (SAR) Symptoms in Ragweed Sensitive Subjects Completed NCT00295022 Phase 4 Placebo;Montelukast;Levocetirizine
41 Effectiveness of Individualized Homeopathic Treatment in Perennial Allergic Rhinitis Completed NCT00822406 Phase 4 homeopathic medicine;placebo
42 Allergic Rhinitis Changes the Sinus Microbiome Completed NCT01852513 Phase 4 QNASL;Placebo nasal spray
43 The Efficacy and Safety of Hyeonggaeyeongyo-tang for Chronic Rhinitis According to Pattern Identification in Korean Medicine Completed NCT02477293 Phase 4 Hyeonggaeyeongyo-tang
44 To Evaluate Adenosine Monophosphate and Allergen Challenge in Allergic Rhinitis Completed NCT00679250 Phase 4 levocetirizine;placebo to levocetirizine
45 Comparison of the Effects of Nasal Steroids and Montelukast on Olfactory Functions in Patients With Allergic Rhinitis Completed NCT02565212 Phase 4 Montelukast,mometazon froat
46 A Clinical Study With Fluticasone Furoate Nasal Spray And Vehicle Placebo For The Treatment Of Perennial (Year-round) Allergic Rhinitis Completed NCT00682643 Phase 4 fluticasone furoate nasal spray;vehicle placebo nasal spray
47 Fluticasone and Salmeterol in Allergic Rhinitis Completed NCT01388595 Phase 4 FLUTICASONE PROPRIONATE;Salmeterol;PLACEBO
48 Alpha-Blockers in Allergic Rhinitis (MAN 01) Completed NCT01946035 Phase 4 Doxazosin XL
49 POPULAR (Preference Of Patient Using Levocetirizine in Allergic Rhinitis) Completed NCT00160537 Phase 4 Levocetirizine
50 Effects of Hypertonic Saline Solution (NACL 3%+NAHCO3) on Nasal Inflammation in Children With AR. RinASol- Pilot Study Completed NCT02729012 Phase 4 hypertonic saline solution (NACL 3%+NAHCO3)

Search NIH Clinical Center for Rhinitis

Inferred drug relations via UMLS 74 / NDF-RT 52 :


Cochrane evidence based reviews: rhinitis

Genetic Tests for Rhinitis

Genetic tests related to Rhinitis:

# Genetic test Affiliating Genes
1 Rhinitis 30

Anatomical Context for Rhinitis

MalaCards organs/tissues related to Rhinitis:

42
Testes, Skin, T Cells, Eye, Pituitary, Neutrophil, Bone

Publications for Rhinitis

Articles related to Rhinitis:

(show top 50) (show all 5537)
# Title Authors Year
1
Efficacy of Sublingual Administration of Dermatophagoides Farinae Drops for Treatment of Pediatric Allergic Rhinitis Accompanied by Adenoid Hypertrophy and Improvement of Immune Function. ( 30633736 )
2019
2
Dendritic cells modified with Der p1 antigen as a therapeutic potential for allergic rhinitis in a murine model via regulatory effects on IL-4, IL-10 and IL-13. ( 30851701 )
2019
3
Nonylphenol can aggravate allergic rhinitis in a murine model by regulating important Th cell subtypes and their associated cytokines. ( 30851706 )
2019
4
Association of antimicrobial household exposure with development of allergic rhinitis in Korea. ( 30861215 )
2019
5
Recent Patents in Allergy/Immunology: Use of arginase inhibitors in the treatment of asthma and allergic rhinitis. ( 30865303 )
2019
6
The Comparation of Intraperitoneal Injection and Nasal-only Delivery Allergic Rhinitis Model Challenged With Different Allergen Concentration. ( 30871345 )
2019
7
The ameliorative effect of AST2017-01 in an ovalbumin-induced allergic rhinitis animal model. ( 30874868 )
2019
8
Consensus on the methodology for experimental studies in allergic rhinitis. ( 30877977 )
2019
9
Epigenetic changes: An emerging potential pharmacological target in allergic rhinitis. ( 30878818 )
2019
10
Triamcinolone Acetonide versus Fluticasone Propionate in the Treatment of Perennial Allergic Rhinitis: A Randomized, Parallel-Group Trial. ( 30879006 )
2019
11
Gallic acid alleviates nasal inflammation via activation of Th1 and inhibition of Th2 and Th17 in a mouse model of allergic rhinitis. ( 30884431 )
2019
12
Bronchial asthma triggered by house dust mites in patients with local allergic rhinitis. ( 30887534 )
2019
13
Life-long endogenous estrogen exposure is associated with prevalence of allergic rhinitis in postmenopausal women. ( 30889092 )
2019
14
Metabolomics analysis of baicalin on ovalbumin-sensitized allergic rhinitis rats. ( 30891260 )
2019
15
Prevalence of local allergic rhinitis to Dermatophagoides pteronyssinus in chronic rhinitis with negative skin prick test. ( 30903999 )
2019
16
A Prospective Study of Outcomes of Septoplasty with Turbinate Reductions in Patients with Allergic Rhinitis. ( 30909804 )
2019
17
Efficacy and safety of olopatadine/mometasone combination nasal spray for the treatment of seasonal allergic rhinitis. ( 30910440 )
2019
18
Effect of Prostaglandin E1 Analog Misoprostol in An Ovalbumin-Induced Allergic Rhinitis Model. ( 30911262 )
2019
19
Powder Cellulose in Allergic Rhinitis Management: Relevance of in vitro Findings to Real-Life Safety. ( 30913556 )
2019
20
Clinical Response to Subcutaneous Dermatophagoides pteronyssinus Immunotherapy in Children with Allergic Rhinitis and Asthma Is Independent of Sensitization to Blomia tropicalis Allergens. ( 30544116 )
2019
21
The protective role of Piper nigrum fruit extract in an ovalbumin-induced allergic rhinitis by targeting of NFκBp65 and STAT3 signalings. ( 30551446 )
2019
22
Suppressive Activity of Adiponectin on the Development of Allergic Rhinitis in Mice. ( 30587608 )
2019
23
The relationship between IL-17A and IL-22 expression and clinical severity in patients with moderate/severe persistent allergic rhinitis. ( 30594402 )
2019
24
The Characteristics of Severe Chronic Upper-Airway Disease (SCUAD) in Patients with Allergic Rhinitis: A Real-Life Multicenter Cross-Sectional Italian Study. ( 30605899 )
2019
25
Acupuncture as an add-on therapy to sublingual allergen-specific immunotherapy for patients with allergic rhinitis. ( 30608427 )
2019
26
Early-Life Environmental Factors, IFN-γ Methylation Patterns, and Childhood Allergic Rhinitis. ( 30612129 )
2019
27
Bioinformatics-Based Approaches Predict That MIR-17-5P Functions in the Pathogenesis of Seasonal Allergic Rhinitis Through Regulating ABCA1 and CD69. ( 30616374 )
2019
28
The role of anxious temperament in patients with allergic rhinitis. ( 30617380 )
2019
29
Antihistamines for Allergic Rhinitis Treatment from the Viewpoint of Nonsedative Properties. ( 30626077 )
2019
30
Effectiveness of Hypertonic Saline Nasal Irrigation for Alleviating Allergic Rhinitis in Children: A Systematic Review and Meta-Analysis. ( 30634447 )
2019
31
Differential Expression of Fas in Moderate/Severe and Mild Persistent Allergic Rhinitis and Its Correlation With Pathological Parameters. ( 30648403 )
2019
32
Intranasal Steroid Therapy for Allergic Rhinitis. ( 30653642 )
2019
33
Impact of moderate-severe persistent allergic rhinitis on thoraco-abdominal kinematics and respiratory muscle function. ( 30656995 )
2019
34
Chinese herbal medicine bi min fang for allergic rhinitis: protocol for a double-blind, double-dummy, randomized controlled trial. ( 30658660 )
2019
35
MP-AzeFlu provides rapid and effective allergic rhinitis control: results of a non-interventional study in Denmark. ( 30659752 )
2019
36
Biosynthesis of gold nanoparticles using Caffeoylxanthiazonoside, chemical isolated from Xanthium strumarium L. fruit and their Anti-allergic rhinitis effect- a traditional Chinese medicine. ( 30660926 )
2019
37
Increasing Prevalence of Allergic Rhinitis in China. ( 30661309 )
2019
38
Intranasal Treatment With 1, 25-Dihydroxyvitamin D3 Alleviates Allergic Rhinitis Symptoms in a Mouse Model. ( 30661318 )
2019
39
IL-37 attenuates allergic process via STAT6/STAT3 pathways in murine allergic rhinitis. ( 30665041 )
2019
40
Stem cells from human exfoliated deciduous teeth correct the immune imbalance of allergic rhinitis via Treg cells in vivo and in vitro. ( 30670101 )
2019
41
Decreased Treg-derived miR-181a and miR-155 correlated with reduced number and function of Treg cells in allergic rhinitis children. ( 30673848 )
2019
42
New drugs in early-stage clinical trials for allergic rhinitis. ( 30676119 )
2019
43
Efficacy of a Novel Intranasal Formulation of Azelastine Hydrochloride and Fluticasone Propionate, Delivered in a Single Spray, for the Treatment of Seasonal Allergic Rhinitis: Results from Russia. ( 30677766 )
2019
44
Detection of Local Allergic Rhinitis in children with chronic, difficult-to-treat, non-allergic rhinitis using Multiple Nasal Provocation Tests. ( 30685887 )
2019
45
Interleukin-5 induces apoptotic defects in CD4+ T cells of patients with allergic rhinitis. ( 30694585 )
2019
46
Effects of Intranasal Cellulose Powder on Asthma Control in Children With Mild-to-Moderate Perennial Allergic Rhinitis: A Randomized, Placebo-Controlled Trial. ( 30704266 )
2019
47
Prevalence of symptoms of asthma and allergic rhinitis in children in Southern Brazil: a ten-year monitoring study. ( 30720381 )
2019
48
Fast up-dosing with a birch allergoid is safe and well tolerated in allergic rhinitis patients with or without asthma. ( 30730274 )
2019
49
The association between allergic rhinitis and otitis media: A national representative sample of in South Korean children. ( 30733549 )
2019
50
Early molecular biomarkers predicting the evolution of allergic rhinitis and its comorbidities: A longitudinal multicenter study of a patient cohort. ( 30734368 )
2019